IgA nephropathy: Immune mechanisms beyond IgA mesangial deposition

Mesangial Proliferation in Murine Experimental IgA Nephropathy

The therapeutic effects of saccharolytic and proteolytic enzymes were investigated in models of IgA nephropathy. Mesangial glomerulonephritis was induced in mice by intravenous injection of preformed soluble immune complexes of dextran sulfate and either IgA (J 558) or IgM (MOPC 104 E) antidextran MAb (passive model) or by immunization with DEAE dextran (active model). In the passive model, onl...

Silicosis associated with crescentic IgA mesangial nephropathy.

Recurrent haematuria and mesangial IgA deposition.

Six patients are described in whom recurrent haematuria was associated with IgA deposits in the glomerular mesangium. These patients conform closely to the nephropathy described by Berger. The condition can only be definitely diagnosed by immunofluorescence techniques. These six patients were diagnosed in one renal unit within 18 months and, despite the absence of reports from British units, th...

The glomerular response to IgA deposition in IgA nephropathy.

Compelling evidence points to a role for IgA receptors in the pathogenesis of IgA nephropathy. The soluble form of the type I IgA receptor (FcalphaRI or CD89) forms complexes with IgA that can be found in patients' serum and that initiate the disease in CD89 transgenic mice. A nonclassic IgA receptor, identified as the transferrin receptor (TfR), is highly expressed in patients' mesangium and c...

IgG deposition in IgA nephropathy patients

IgA nephropathy is the most common form of glomerular disease among young adults. The aim of this study is to determine the correlation of IgG deposition with morphologic variables of Oxford classification and some clinical data of patients with IgA nephropathy (IgAN).A total of 114 biopsies were enrolled to the study (70.2% were male). Mean age of the patients was 37.7±13.6 years. This study s...